// App-Quantinova.ai

PB0438 : The Presence of Anti-Phosphatidylserine/Prothrombin Antibodies Enhance Differences in the Thrombin Generation Phenotype among Subjects with Lupus Anticoagulant Not Meeting Antiphospholipid Syndrome Criteria

Researchers

Presenter

  • D. Velasco-Rodrguez

Principal Investigators

  • R. Vidal Laso

  • A. Garca-Raso

  • I. Mahllo Fernndez

  • K. Guzmn-Lpez

  • S. Martn Herrero

  • E. Jimnez Barral

  • M.D.C. Vegas-Snchez

  • M.J. Martnez Becerra

  • J.M. Alonso-Domnguez

  • C. Blas Lpez

  • R. de la Plaza

  • L.F. Lpez Romero

  • D. Mnguez

  • A. Garca Lpez

  • M.S. Snchez Fernndez

  • P. Llamas-Sillero

Medical Centers

  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Lupus

Biomarkers

  • Prothrombin

Drug/Treatment

  • Phosphatidylserine

  • Thrombomodulin alfa

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved